Garner Ebun
SEC CIK 1364554 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ERAS | Erasca, Inc. | GC, Corp. Sec | 105.1K | $14.4K | $1.98M | 10 | 2021-07-20 | 2026-04-01 |
Most active insiders at ERAS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Garner Ebun | GC, Corp. Sec | — | $1.98M |
| 2 | Morris Shannon | Chief Medical Off | — | $300.8K |
| 3 | Chacko David M. | CFO, CBO | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-03 09:00 | 2026-04-01 | ERAS | Erasca, Inc. | Garner Ebun | CLO | M - OptEx | $1.70 | +80.0K | 105.1K | +319% | +$136.0K |
| DT | 2026-04-03 09:00 | 2026-04-01 | ERAS | Erasca, Inc. | Garner Ebun | CLO | S - Sale+OE | $16.40 | -80.0K | 25.1K | -76% | -$1.31M |
| DT | 2026-01-08 | 2025-12-15 | ERAS | Erasca, Inc. | Garner Ebun | GC, Corp. Sec | A - Grant | $1.19 | +3,902 | 25.1K | +18% | +$4,643 |
| DT | 2026-01-08 | 2026-01-07 | ERAS | Erasca, Inc. | Garner Ebun | GC, Corp. Sec | S - Sale+OE | $5.59 | -120.0K | 25.1K | -83% | -$670.8K |
| DT | 2026-01-08 | 2026-01-07 | ERAS | Erasca, Inc. | Garner Ebun | GC, Corp. Sec | M - OptEx | $1.70 | +120.0K | 145.1K | +479% | +$204.0K |
| DM | 2025-02-05 | 2024-06-14+ | ERAS | Erasca, Inc. | Garner Ebun | GC, Corp. Sec | J - Other | $1.56 | +11.4K | 21.2K | +118% | +$17.9K |
| 2023-12-18 | 2023-12-15 | ERAS | Erasca, Inc. | Garner Ebun | GC, Corp. Sec | J - Other | $1.59 | +5,448 | 9,728 | +127% | +$8,662 | |
| DM | 2023-02-03 | 2023-02-01 | ERAS | Erasca, Inc. | Garner Ebun | GC, Corp. Sec | J - Other | $4.10 | +2,390 | 4,280 | +126% | +$9,799 |
| D | 2022-02-03 | 2022-02-01 | ERAS | Erasca, Inc. | Garner Ebun | GC, Corp. Sec | J - Other | $11.60 | +990 | 1,890 | +110% | +$11.5K |
| 2021-07-20 | 2021-07-20 | ERAS | Erasca, Inc. | Garner Ebun | GC | P - Purchase | $16.00 | +900 | 900 | New | +$14.4K |
Purchase Sale Sale after option exercise All abbreviations